Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
Background and Aims. To establish the efficacy and safety of ilaprazole, levofloxacin, and amoxicillin as a first-line eradication treatment for Helicobacter pylori. Methods. Patients with gastric ulcer, duodenal ulcer, or gastritis, as detected by esophagogastroduodenoscopy with confirmed H. pylori...
Saved in:
Main Authors: | Hyo Jun Ahn, Dong Pil Kim, Myeong Su Chu, Hyeon Jeong Yun, Seok-Hwan Kim, Seung Woo Lee, Dong Soo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/1654907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
by: WonGun Kwack, et al.
Published: (2016-01-01) -
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
by: Wei-Chen Tai, et al.
Published: (2013-01-01) -
The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis
by: Jong-Min Lee, et al.
Published: (2012-01-01) -
Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy
by: Veronica Ojetti, et al.
Published: (2012-01-01) -
Association between Genetic Instability and Helicobacter pylori Infection in Gastric Epithelial Dysplasia
by: Jin Su Kim, et al.
Published: (2012-01-01)